Back to Search
Start Over
Moderna Covid-19 vaccine, Spikevax manufactured in Korea by Samsung Biologics gets Korean MFDS marketing authorization
- Source :
- PharmaBiz. December 15, 2021
- Publication Year :
- 2021
-
Abstract
- Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevax, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.686903390